+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A prospective, randomized, controlled study to compare two doses of recombinant human chorionic gonadotropin in serum and follicular fluid in woman with high body mass index



A prospective, randomized, controlled study to compare two doses of recombinant human chorionic gonadotropin in serum and follicular fluid in woman with high body mass index



Fertility and Sterility 93(6): 2084-2087



This prospective, randomized, controlled study compares the efficiency of 250 microg or 500 microg of recombinant hCG in serum and follicular fluid (FF) levels and pregnancy rates (PR) in women with high body mass index (BMI) (>or=26 kg/m(2)) undergoing assisted reproduction treatment (ART). Treatment outcomes are similar between the two groups.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051222847

Download citation: RISBibTeXText

PMID: 19782346

DOI: 10.1016/j.fertnstert.2009.08.026


Related references

A prospective, randomized, double-blind study to compare two doses of recombinant human chorionic gonadotropin in inducing final oocyte maturity and the hormonal profile during the luteal phase. Journal of Clinical Endocrinology and Metabolism 90(7): 3933-3938, 2005

Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization. Fertility and Sterility 90(6): 2133-2137, 2008

Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization-embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection. Fertility & Sterility 75(4): 700-704, 2001

Maternal body mass index and serum concentrations of human chorionic gonadotropin in very early pregnancy. Fertility and Sterility 98(4): 905-910, 2012

Serum human chorionic gonadotropin level after ovulation triggering is influenced by the patient's body mass index and the number of larger follicles. Fertility and Sterility 88(1): 152-155, 2007

Effects of the thyromimetic agent diiodothyropropionic acid on body weight, body mass index, and serum lipoproteins: a pilot prospective, randomized, controlled study. Journal of Clinical Endocrinology and Metabolism 95(3): 1349-1354, 2010

Interaction between cow follicular fluid and anti serum and human chorionic gonadotropin. Archivos de Biologia y Medicina Experimentales 7(1-2-3): R16, 1970

Intrauterine insemination with recombinant or urinary human chorionic gonadotropin: A prospective randomized trial. Gynecological Endocrinology 24(11): 644-648, 2008

1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study. Fertility and Sterility 93(3): 847-854, 2010

Sonography as a determination of human chorionic gonadotropin injection a retrospective study of hormones in serum and follicular fluid. Journal of In Vitro Fertilization & Embryo Transfer 1(2): 130, 1984

Successful pregnancy in a woman with Kallmann's syndrome using human menopausal gonadotropin followed by low-dose human chorionic gonadotropin in the mid-to-late follicular phase. Taiwanese Journal of Obstetrics and Gynecology 51(2): 300-302, 2012

A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study. Fertility and Sterility 95(3): 1174-1177, 2011

Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial. Fertility and Sterility 86(4): 830-838, 2006

Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial. Fertility and Sterility 96(5): 1112-1115, 2011

Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low-dose human chorionic gonadotropin: a randomized, controlled trial. Fertility and Sterility 99(1): 132-139, 2013